Pediatric DXA: Clinical applications

Pediatric Radiology

Volumn 37, Issue 7, 2007, Pages 625-635

  Binkovitz, Larry A ^a   Sparke, Paul ^b   Henwood, Maria J ^a  

^a NATIONWIDE CHILDREN S HOSPITAL   (United States)

^b CAPITAL UNIVERSITY   (United States)

Author keywords

Bone mineral density; DXA; Osteoporosis; Pediatrics

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CORTICOSTEROID; ESTROGEN; GLUCOCORTICOID; GROWTH HORMONE; INSULIN; MEDROXYPROGESTERONE ACETATE; METHOTREXATE; ORAL CONTRACEPTIVE AGENT; PARATHYROID HORMONE; PHOSPHATE; PROGESTERONE; TESTOSTERONE; VITAMIN D;

ACUTE LYMPHOCYTIC LEUKEMIA; ANOREXIA NERVOSA; ASTHMA; BONE DENSITY; BONE METABOLISM; BONE MINERAL; CALCIUM INTAKE; CLINICAL TRIAL; CONNECTIVE TISSUE DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG MEGADOSE; DUAL ENERGY X RAY ABSORPTIOMETRY; DUCHENNE MUSCULAR DYSTROPHY; ENDOCRINE DISEASE; GASTROINTESTINAL DISEASE; HEMATOLOGIC DISEASE; HUMAN; HYPOXIA; KIDNEY DISEASE; LIVER DISEASE; MILK ALLERGY; NEUROLOGIC DISEASE; OSTEOPOROSIS; PARATHYROID HORMONE BLOOD LEVEL; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; REVIEW; SIDE EFFECT;

ABSORPTIOMETRY, PHOTON; BONE DENSITY; CHILD; CONTRAST MEDIA; HUMANS; OSTEOPOROSIS;

EID: 34250660133     PISSN: 03010449     EISSN: 14321998     Source Type: Journal    
DOI: 10.1007/s00247-007-0450-0     Document Type: Review

References (131)

1. Binkovitz LA, Henwood MJ (2007) Pediatric DXA technique and interpretation. Pediatr Radiol 37:21-31
2. Henderson RC, Hayes PRL (1994) Bone mineralization in children and adolescents with a milk allergy. Bone Miner 27:1-12
3. Infante D, Tormo R (2000) Risk of inadequate bone mineralization in diseases involving long-term suppression of dairy products. J Pediatr Gastroenterol Nutr 30:310-313
4. Rockwell JE, Williams SM, Taylor RW et al (2005) Two-year changes in bone and body composition in young children with a history of prolonged milk avoidance. Osteoporos Int 15:1016-1023
5. Boot AM, Bouquet J, Krenning EP et al (1998) Bone mineral density and nutritional status in children with chronic inflammatory bowel disease. Gut 42:188-194
6. Ahmed SF, Horrocks IA, Patterson T et al (2004) Bone mineral assessment by dual energy x-ray absorptiometry in children with inflammatory bowel disease: Evaluation by age or bone area. J Pediatr Gastroenterol Nutr 38:276-281
7. Burnham JM, Shults J, Semeao E et al (2004) Whole body BMC in pediatric Crohn disease: Independent effects of altered growth, maturation, and body composition. J Bone Miner Res 19:1961-1968
8. Walther F, Fusch C, Radke M et al (2006) Osteoporosis in pediatric patients suffering from chronic inflammatory bowel disease with and without steroid treatment. J Pediatr Gastroenterol Nutr 43:42-51
9. Kalayci AG, Kkansu A, Girgin N et al (2001) Bone mineral density and importance of a gluten-free diet in patients with celiac disease in childhood. Pediatrics 108:e89
10. Barera G, Beccio S, Proverbio MC et al (2004) Longitudinal changes in bone metabolism and bone mineral content in children with celiac disease during consumption of a gluten-free diet. Am J Clin Nutr 79:148-154
11. Tau C, Mautalen C, De Rosa S et al (2006) Bone mineral density in children with celiac disease. Effect of a gluten-free diet. Eur J Clin Nutr 60:358-363
12. Szathmari M, Tulassay T, Arato A et al (2001) Bone mineral content and density in asymptomatic children with celiac disease on a gluten-free diet. Eur J Gastroenterol Hepatol 13:419-424
13. Argao EA, Specker BL, Heubi JE (1993) Bone mineral content in infants and children with chronic cholestatic liver disease. Pediatrics 91:1151-1154
14. Olsen IE, Ittenbach RF, Rovner AJ et al (2005) Deficits in size-adjusted bone mass in children with Alagille syndrome. J Pediatr Gastroenterol Nutr 40:76-82
15. D'Antiga L, Ballan D, Luisetto G et al (2004) Long-term outcome of bone mineral density in children who underwent a successful liver transplantation. Transplantation 78:899-903
16. Bakr AM (2004) Bone mineral density and bone turnover markers in children with chronic renal failure. Pediatr Nephrol 19:1390-1393
17. Pluskiewicz W, Adamczyk P, Drozdzowska B et al (2005) Skeletal status in adolescents with end-stage renal failure: A longitudinal study. Osteoporos Int 16:289-295
18. Ahmed SF, Russell S, Rashid R et al (2005) Bone mineral content, corrected for height or bone area, measured by DXA is not reduced in children with chronic renal disease or in hypoparathyroidism. Pediatr Nephrol 20:1466-1472
19. Acott PD, Crocker JFS, Wong JA (2003) Decreased bone mineral density in the pediatric renal transplant population. Pediatr Transplant 7:358-363
20. Boot AM, Nauta J, de Jong MC et al (1998) Bone mineral density, bone metabolism and body composition of children with chronic renal failure, with and without growth hormone treatment. Clin Endocrinol 49:665-672
21. Van der Sluis IM, Boot AM, Nauta J et al (2000) Bone density and body composition in chronic renal failure: Effects of growth hormone treatment. Pediatr Nephrol 15:221-228
22. Feber J, Cochat P, Braillon P et al (1994) Bone mineral density after renal transplantation in children. J Pediatr 125(6pt1):870-875
23. Klaus G, Paschen C, Wuster C et al (1998) Weight/height-related bone mineral density is not reduced after renal transplantation. Pediatr Nephrol 12:343-348
24. Ellis EN, Floyd-Gimon DM, Berry PL et al (2000) Risk factors for bone mineral density loss in pediatric renal transplant patients. Pediatr Transplant 4:146-150
25. Freundlich M, Alonzo E, Bellorin-Font E et al (2002) Reduced bone mass in children with idiopathic hypercalciuria and in their asymptomatic mothers. Nephrol Dial Transplant 17:1396-1401
26. Garcia-Nieto V, Navarro JF, Monge M et al (2003) Bone mineral density in girls and their mothers with idiopathic hypercalciuria. Nephron Clin Pract 94:c89-c93
27. Penido MG, Lima EM, Marino VS et al (2003) Bone alterations in children with idiopathic hypercalciuria at the time of diagnosis. Pediatr Nephrol 18:133-139
28. Skalova S, Palicka V, Kutilek S (2005) Bone mineral density and urinary N-acetyl-beta-D-glucosaminidase activity in paediatric patients with idiopathic hypercalciuria. Nephrology (Carlton) 10:99-102
29. Bonjour JP, Theintz G, Buchs B et al (1991) Critical years and stages of puberty for spinal and femoral bone mass accumulation during adolescence. J Clin Endocrinol Metab 73:555-563
30. Takahashi Y, Minamitani K, Kobayashi Y et al (1996) Spinal and femoral bone mass accumulation during normal adolescence: Comparison with female patients with sexual precocity and with hypogonadism. J Clin Endocrinol Metab 81:1248-1253
31. Unal O, Berberoglu M, Evliyaoglu O et al (2003) Effects on bone mineral density of gonadotropin releasing hormone analogs used in the treatment of central precocious puberty. J Pediatr Endocrinol Metab 16:407-411
32. Saggese G, Baroncelli GI, Bertelloni S et al (1996) The effect of long-term growth hormone (GH) treatment on bone mineral density in children with GH deficiency. Role of GH in the attainment of peak bone mass. J Clin Endocrinol Metab 81:3077-3083
33. Hogler W, Briody J, Moore B et al (2005) Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency. Bone 37:642-650
34. Lanes R, Gunczler P, Esaa S et al (2002) The effect of short- and long-term growth hormone treatment on bone mineral density and bone metabolism of prepubertal children with idiopathic short stature: A 3-year study. Clin Endocrinol (Oxf) 57:725-730
35. Baroncelli GI, Bertelloni S, Sodini F et al (2004) Longitudinal changes of lumbar bone mineral density (BMD) in patients with GH deficiency after discontinuation of treatment at final height; timing and peak values for lumbar BMD. Clin Endocrinol (Oxf) 60:175-184
36. Baroncelli GI, Saggese G (2005) Effect of GH treatment on bone mass in children with GH deficiency. J Endocrinol Invest 28(10 Suppl):23-27
37. Moyer-Mileur LJ, Dixon SB, Quick JL et al (2004) Bone mineral acquisition in adolescents with type 1 diabetes. J Pediatr 145:662-669
38. Gunczler P, Lanes R, Paz-Martinez V et al (1998) Decreased lumbar spine bone mass and low bone turnover in children and adolescents with insulin dependent diabetes mellitus followed longitudinally. J Pediatr Endocrinol Metab 11:413-419
39. Karaguzel G, Akcurin S, Ozdem S et al (2006) Bone mineral density and alterations of bone metabolism in children and adolescents with type 1 diabetes mellitus. J Pediatr Endocrinol Metab 19:805-814
40. Valerio G, del Puente A, Esposito-del Puente A et al (2002) The lumbar bone mineral density is affected by long-term poor metabolic control in adolescents with type 1 diabetes mellitus. Horm Res 58:266-272
41. Heap J, Murray MA, Miller SC et al (2004) Alterations in bone characteristics associated with glycemic control in adolescents with type 1 diabetes mellitus. J Pediatr 144:55-62
42. Mora S, Saggion F, Russo G et al (1996) Bone density in young patients with congenital adrenal hyperplasia. Bone 18:337-340
43. Guo CY, Weetman AP, Eastell R (1996) Bone turnover and bone mineral density in patients with congenital adrenal hyperplasia. Clin Endocrinol (Oxf) 45:535-541
44. King JA, Wisniewski AB, Bankowski BJ et al (2006) Long-term corticosteroid replacement and bone mineral density in adult women with classical congenital adrenal hyperplasia. J Clin Endocrinol Metab 91:865-869
45. Di Somma C, Pivonello R, Loche S et al (2002) Severe impairment of bone mass and turnover in Cushing's disease: Comparison between childhood-onset and adulthood-onset disease. Clin Endocrinol (Oxf) 56:153-158
46. Di Somma C, Pivonello R, Loche S, et al (2003) Effect of 2 years of cortisol normalization on the impaired bone mass and turnover in adolescent and adult patients with Cushing's disease: A prospective study. Clin Endocrinol (Oxf) 58:302-308
47. Shoepe HA, Snow CM (2005) Oral contraceptive use in young women is associated with lower bone mineral density than that of controls. Osteoporos Int 16:1538-1544
48. Cromer BA, Stager M, Bonny A et al (2004) Depot medroxyprogesterone acetate, oral contraceptives and bone mineral density in a cohort of adolescent girls. J Adolesc Health 35:434-441
49. Cromer BA, Blair JM, Mahan JD et al (1996) A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives. J Pediatr 129:671-676
50. Banks E, Berrington A, Casabonne D (2001) Overview of the relationship between use of progestogen-only contraceptives and bone mineral density. BJOG 108:1214-1221
51. Cromer BA, Lazebnik R, Rome E et al (2005) Double-blinded randomized controlled trial of estrogen supplementation in adolescent girls who receive depot medroxyprogesterone acetate for contraception. Am J Obstet Gynecol 192:42-47
52. Resch H, Newrkla S, Grampp S et al (2000) Ultrasound and x-ray-based bone densitometry in patients with anorexia nervosa. Calcif Tissue Int 66:338-341
53. Soyka LA, Misra M, Frenchman A et al (2002) Abnormal bone mineral accrual in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab 87:4177-4185
54. Milos G, Spindler A, Ruegsegger P et al (2005) Cortical and trabecular bone density and structure in anorexia nervosa. Osteoporos Int 16:783-790
55. Biller BM, Saxe V, Herzog DB et al (1989) Mechanisms of osteoporosis in adult and adolescent women with anorexia nervosa. J Clin Endocrinol Metab 68:548-554
56. Kooh SW, Noriega E, Leslie K et al (1996) Bone mass and soft tissue composition in adolescents with anorexia nervosa. Bone 19:181-188
57. Seeman E, Szmukler GI, Formica C et al (1992) Osteoporosis in anorexia nervosa: The influence of peak bone density, bone loss, oral contraceptive use, and exercise. J Bone Miner Res 7:1467-1474
58. Kooh SW, Brnjac L, Ehrlich RM et al (1996) Bone mass in children with congenital hypothyroidism treated with thyroxine since birth. J Pediatr Endocrinol Metab 9:59-62
59. Leger J, Ruiz JC, Guibourdenche J et al (1997) Bone mineral density and metabolism in children with congenital hypothyroidism after prolonged L-thyroxine therapy. Acta Paediatr 86:704-710
60. Salerno M, Lettiero T, Puente AE et al (2004) Effect of long-term L-thyroxine treatment on bone mineral density in young adults with congenital hypothyroidism. Eur J Endocrinol 151:689-694
61. Saggese G, Bertelloni S, Baroncelli GI et al (1996) Bone mineral density in adolescent females treated with L-thyroxine: A longitudinal study. Eur J Pediatr 155:452-457
62. Lucidarme N, Ruiz JC, Czernichow P et al (2000) Reduced bone mineral density at diagnosis and bone mineral recovery during treatment in children with Graves' disease. J Pediatr 137:56-62
63. Sood M, Hambleton G, Super M et al (2001) Bone status in cystic fibrosis. Arch Dis Child 84:516-520
64. Haslam RH, Borovnicar DJ, Stroud DB et al (2001) Correlates of prepubertal bone mineral density in cystic fibrosis. Arch Dis Child 85:166-171
65. Hardin DS, Arumugam R, Seilheimer DK et al (2001) Normal bone mineral density in cystic fibrosis. Arch Dis Child 84:363-368
66. Buntain HM, Greer RM, Schluter PJ et al (2004) Bone mineral density in Australian children, adolescents and adults with cystic fibrosis: A controlled cross sectional study. Thorax 59:149-155
67. Haworth CS, Selby PL, Webb AK et al (1999) Low bone mineral density in adults with cystic fibrosis. Thorax 54:961-967
68. Henderson RC, Madsen CD (1996) Bone density in children and adolescents with cystic fibrosis. J Pediatr 128:28-39
69. Haworth CS, Selby PL, Horrocks AW et al (2002) A prospective study of change in bone mineral density over one year in adults with cystic fibrosis. Thorax 57:719-723
70. Bhudhikanok GS, Wang MC, Marcus R et al (1998) Bone acquisition and loss in children and adults with cystic fibrosis: A longitudinal study. J Pediatr 33:18-27
71. Aris RM, Lester GE, Renner JB et al (2000) Efficacy of pamidronate for osteoporosis in patients with cystic fibrosis following lung transplantation. Am J Respir Crit Care Med 162:941-946
72. Aris RM, Lester GE, Caminiti M et al (2004) Efficacy of alendronate in adults with cystic fibrosis with low bone density. Am J Respir Crit Care Med 169:77-82
73. Haworth CS, Selby PL, Adams JE et al (2001) Effect of intravenous pamidronate on bone mineral density in adults with cystic fibrosis. Thorax 56:314-316
74. Boot AM, de Jongste JC, Verberne AA et al (1997) Bone mineral density and bone metabolism of prepubertal children with asthma after long-term treatment with inhaled corticosteroids. Pediatr Pulmonol 24:379-384
75. Agertoft L, Pedersen S (1998) Bone mineral density in children with asthma receiving long-term treatment with inhaled budesonide. Am J Respir Crit Care Med 157:178-183
76. Bahceciler NN, Sezgin G, Nursoy MA et al (2002) Inhaled corticosteroids and bone density of children with asthma. J Asthma 39:151-157
77. Altzntas DU, Karakoc GB, Can S et al (2005) The effects of long term use of inhaled corticosteroids on linear growth, adrenal function and bone mineral density in children. Allergol Immunopathol 33:204-209
78. Allen HD, Thong IG, Clifton-Bligh P et al (2000) Effects of high-dose inhaled corticosteroids on bone metabolism in prepubertal children with asthma. Pediatr Pulmonol 29:188-193
79. Harris M, Hauser S, Nguyen TV et al (2001) Bone mineral density in prepubertal asthmatics receiving corticosteroid treatment. J Paediatr Child Health 37:67-71
80. Brinker MR, Thomas KA, Meyers SJ et al (1998) Bone mineral density of the lumbar spine and proximal femur is decreased in children with sickle cell anemia. Am J Orthop 27:43-49
81. Soliman AT, Bererhi H, Darwish A et al (1998) Decreased bone mineral density in prepubertal children with sickle cell disease: Correlation with growth parameters, degree of siderosis and secretion of growth factors. J Trop Pediatr 44:194-198
82. Lal A, Fung EB, Pakbaz Z et al (2006) Bone mineral density in children with sickle cell anemia. Pediatr Blood Cancer 47:901-906
83. Buison AM, Kawchak DA, Schall JI et al (2005) Bone area and bone mineral content deficits in children with sickle cell disease. Pediatrics 116:943-949
84. Ahmed S, Siddique S, Rice T et al (2006) High prevalence and correlates of low bone mineral density in young adults with sickle cell disease. Am J Hematol 81:236-241
85. Vogiatzi MG, Autio KA, Schneider R et al (2004) Low bone mass in prepubertal children with thalassemia major: Insights into the pathogenesis of low bone mass in thalassemia. J Pediatr Endocrinol Metab 17:1415-1421
86. Benigno V, Bertelloni S, Baroncelli GI et al (2003) Effects of thalassemia major on bone mineral density in late adolescence. J Pediatr Endocrinol Metab 16:337-342
87. Barnes C, Wong P, Egan B et al (2004) Reduced bone density among children with severe hemophilia. Pediatrics 114:177-181
88. Gallacher SJ, Deighan C, Wallace AM et al (1994) Association of severe haemophilia A with osteoporosis: A densitometric and biochemical study. Q J Med 87:181-186
89. Arikoski P, Komulainen J, Voutilainen R et al (1998) Reduced bone mineral density in long-term survivors of childhood acute lymphoblastic leukemia. J Pediatr Hematol Oncol 20:234-240
90. Brennan BM, Rahim A, Adams JA et al (1999) Reduced bone mineral density in young adults following cure of acute lymphoblastic leukaemia in childhood. Br J Cancer 79:1859-1863
91. van der Sluis IM, van den Heuvel-Eibrink MM, Hahlen K et al (2000) Bone mineral density, body composition, and height in long-term survivors of acute lymphoblastic leukemia in childhood. Med Pediatr Oncol 35:415-420
92. Boot AM, van den Heuvel-Eibrink MM, Hahlen K et al (1999) Bone mineral density in children with acute lymphoblastic leukaemia. Eur J Cancer 35:1693-1697
93. Marinovic D, Dorgeret S, Lescoeur B et al (2005) Improvement in bone mineral density and body composition in survivors of childhood acute lymphoblastic leukemia: A 1-year prospective study. Pediatrics 116:e102-e108
94. Jarfelt M, Fors H, Lannering B et al (2006) Bone mineral density and bone turnover in young adult survivors of childhood acute lymphoblastic leukaemia. Eur J Endocrinol 154:303-309
95. Aisenberg J, Hsieh K, Kalaitzoglou G (1998) Bone mineral density in young adult survivors of childhood cancer. Hematol Oncol 20:241-245
96. Vassilopoulou-Sellin R, Brosnan P, Delpassand A et al (1999) Osteopenia in young adult survivors of childhood cancer. Med Pediatr Oncol 32:272-278
97. Nysom K, Holm K, Michaelsen KF et al (2001) Bone mass after treatment of malignant lymphoma in childhood. Med Pediatr Oncol 37:518-524
98. Kelly J, Damron T, Grant W et al (2005) Cross-sectional study of bone mineral density in adult survivors of solid pediatric cancers. J Pediatr Hematol Oncol 27:248-253
99. Ruza E, Sierrasesumaga L, Azcona C et al (2006) Bone mineral density and bone metabolism in children treated for bone sarcomas. Pediatr Res 59:866-871
100. Odame I, Duckworth J, Talsma D et al (2006) Osteopenia, physical activity and health-related quality of life in survivors of brain tumors treated in childhood. Pediatr Blood Cancer 46:357-362
101. Harcke HT, Taylor A, Bachrach S et al (1998) Lateral femoral scan: An alternative method for assessing bone mineral density in children with cerebral palsy. Pediatr Radiol 28:241-246
102. Henderson RC, Lark RK, Newman JE et al (2002) Pediatric reference data for dual x-ray absorptiometric measures of normal bone density in the distal femur. AJR 178:439-443
103. Henderson RC, Lin PP, Greene WB (1995) Bone-mineral density in children and adolescents who have spastic cerebral palsy. J Bone Joint Surg Am 77:1671-1681
104. Henderson RC, Lark RK, Gurka MJ et al (2002) Bone density and metabolism in children and adolescents with moderate to severe cerebral palsy. Pediatrics 110:1-10
105. Henderson RC, Kairalla JA, Barrington JW et al (2005) Longitudinal changes in bone density in children and adolescents with moderate to severe cerebral palsy. J Pediatr 146:769-775
106. Henderson RC, Lark RK, Kecskemethy HH et al (2002) Bisphosphonates to treat osteopenia in children with quadriplegic cerebral palsy: A randomized, placebo-controlled clinical trial. J Pediatr 141:644-651
107. Bachrach SJ, Kecskemethy HH, Harcke HT et al (2006) Pamidronate treatment and posttreatment bone density in children with spastic quadriplegic cerebral palsy. J Clin Densitom 9:167-174
108. Quan A, Adams R, Ekmark E et al (1998) Bone mineral density in children with myelomeningocele. Pediatrics 102:e34
109. Quan A, Adams R, Ekmark E et al (2003) Bone mineral density in children with myelomeningocele; effect of hydrochlorothiazide. Pediatr Nephrol 18:929-933
110. Valtonen KM, Goksor LA, Jonsson O et al (2006) Osteoporosis in adults with meningomyelocele: An unrecognized problem at rehabilitation clinics. Arch Phys Med Rehabil 87:376-382
111. Pepmueller PH, Cassidy JT, Allen SH et al (1996) Bone mineralization and bone mineral metabolism in children with juvenile rheumatoid arthritis. Arthritis Rheum 39:746-757
112. Pereira RM, Corrente JE, Chahade WH et al (1998) Evaluation by dual x-ray absorptiometry (DXA) of bone mineral density in children with juvenile chronic arthritis. Clin Exp Rheumatol 16:495-501
113. Lien G, Flato B, Haugen M et al (2003) Frequency of osteopenia in adolescents with early-onset juvenile idiopathic arthritis. Arthritis Rheum 48:2214-2223
114. Henderson CJ, Cawkwell GD, Specker BL et al (1997) Predictors of total body bone mineral density in non-corticosteroid-treated prepubertal children with juvenile rheumatoid arthritis. Arthritis Rheum 40:1967-1975
115. Henderson CJ, Specker BL, Sierra RI et al (2000) Total-body bone mineral content in non-corticosteroid-treated postpubertal females with juvenile rheumatoid arthritis. Arthritis Rheum 43:531-554
116. Mul D, van Suijlekom-Smit LW, ten Cate R et al (2002) Bone mineral density and body composition and influencing factors in children with rheumatic diseases treated with corticosteroids. J Pediatr Endocrinol Metab 15:187-192
117. Bianchi ML, Cimaz R, Galbiati E et al (1999) Bone mass change during methotrexate treatment in patients with juvenile rheumatoid arthritis. Osteoporos Int 10:20-25
118. Trapani S, Civinini R, Ermini M et al (1998) Osteoporosis in juvenile systemic lupus erythematosus: A longitudinal study on the effect of steroids on bone mineral density. Rheumatol Int 18:45-49
119. Castro TC, Terreri MT, Szejnfeld VL et al (2002) Bone mineral density in juvenile systemic lupus erythematosus. Braz J Med Biol Res 35:1159-1163
120. Larson CM, Henderson RC (2000) Bone mineral density and fractures in boys with Duchenne muscular dystrophy. J Pediatr Orthop 20:71-74
121. Bianchi ML, Mazzanti A, Galbiati E et al (2003) Bone mineral density and bone metabolism in Duchenne muscular dystrophy. Osteoporos Int 14:761-776
122. Hawker GA, Ridout R, Harris VA et al (2005) Alendronate in the treatment of low bone mass in steroid-treated boys with Duchenne's muscular dystrophy. Arch Phys Med Rehabil 86:284-288
123. Stewart WA, Acott PD, Salisbury SR et al (2003) Bone mineral density in juvenile dermatomyositis. Arthritis Rheum 48:2294-2298
124. Castro TC, Terreri MT, Szejnfeld VL et al (2005) Bone mineral density of Brazilian girls with juvenile dermatomyositis. Braz J Med Biol Res 38:309-313
125. Lund AM, Molgaard C, Muller J et al (1999) Bone mineral content and collagen defects in osteogenesis imperfecta. Acta Paediatr 88:1083-1088
126. Rauch F, Glorieux FH (2005) Bisphosphonate treatment in osteogenesis imperfecta: Which drug, for whom, for how long? Ann Med 37:295-302
127. Zacharin M, Kanumakala S (2004) Pamidronate treatment in less severe forms of osteogenesis imperfecta. J Pediatr Endocrinol Metab 17:1511-1517
128. Gatti D, Antoniazzi F, Prizzi R et al (2005) Intravenous neridronate in children with osteogenesis imperfecta: A randomized controlled study. J Bone Miner Res 20:758-763
129. Arikoski P, Silverwood B, Tillmann V et al (2004) Intravenous pamidronate in children with moderate to severe osteogenesis imperfecta: assessment of indices of dual-energy X-ray absorptiometry and bone metabolic markers during the first year of therapy. Bone 34:539-546
130. Letocha AD, Cintas HL, Troendle JF et al (2005) Controlled trial of pamidronate in children with types III and IV osteogenesis imperfecta confirms vertebral gains but not short-term functional improvement. J Bone Miner Res 20:977-986
131. Zeitlin L, Rauch F, Plotkin H et al (2003) Height and weight development during four years of therapy with cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta types I, III, and IV. Pediatrics 111(5 Pt 1):1030-1036